tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
Company AnnouncementsNxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
10d ago
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
PremiumCompany Announcements
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
1M ago
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
PremiumCompany Announcements
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
1M ago
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
PremiumCompany Announcements
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
1M ago
Nxera Pharma Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Nxera Pharma Reports Strong Revenue Growth in 2024
2M ago
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
PremiumCompany AnnouncementsNxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
2M ago
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
Premium
Company Announcements
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
2M ago
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
Premium
Company Announcements
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
2M ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
PremiumCompany Announcements
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
4M ago
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
PremiumCompany Announcements
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
5M ago
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
PremiumCompany Announcements
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
5M ago
Nxera Pharma Reports Increased Revenue but Continues to Face Losses
PremiumCompany AnnouncementsNxera Pharma Reports Increased Revenue but Continues to Face Losses
5M ago
Nxera Pharma Reports Key Milestones and Revenue Growth
Premium
Company Announcements
Nxera Pharma Reports Key Milestones and Revenue Growth
5M ago
SOLTF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SOLTF Upcoming Earnings Report: What to Expect?
5M ago
Nxera Pharma Partners with Shionogi on Insomnia Drug
PremiumCompany Announcements
Nxera Pharma Partners with Shionogi on Insomnia Drug
6M ago
Nxera Pharma Secures $35M After Trial Success
PremiumCompany Announcements
Nxera Pharma Secures $35M After Trial Success
7M ago
Nxera Pharma Advances Schizophrenia Treatment
PremiumCompany Announcements
Nxera Pharma Advances Schizophrenia Treatment
7M ago
Nxera notes Phase 2 data for partnered schizophrenia candidate NBI-1117568
PremiumThe Fly
Nxera notes Phase 2 data for partnered schizophrenia candidate NBI-1117568
7M ago
NBIX
Nxera Pharma Posts Revenue Surge Amid Net Loss
PremiumCompany AnnouncementsNxera Pharma Posts Revenue Surge Amid Net Loss
8M ago
Nxera Pharma Shows Robust Q2 Growth and Progress
Premium
Company Announcements
Nxera Pharma Shows Robust Q2 Growth and Progress
8M ago
SOLTF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SOLTF Earnings this Week: How Will it Perform?
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >